You are here

  • Home
  • Archive
  • Volume 6, Issue Suppl 1
  • 3 Polyunsaturated fatty acids (PUFAs) and specialized pro-resolving mediators (SPMs) are decreased in plasma and serum from SLE patients compared to healthy controls

Article info

Article menu

Download PDFPDF

Abstracts
3 Polyunsaturated fatty acids (PUFAs) and specialized pro-resolving mediators (SPMs) are decreased in plasma and serum from SLE patients compared to healthy controls
Free

Authors

Citation

Davis-Porada J, Serhan C, Norris P, et al
3 Polyunsaturated fatty acids (PUFAs) and specialized pro-resolving mediators (SPMs) are decreased in plasma and serum from SLE patients compared to healthy controls
Lupus Science & Medicine 2019;6:doi: 10.1136/lupus-2019-lsm.3

Publication history

  • First published April 5, 2019.
Online issue publication 
May 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions